 |
|
Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study
David G. Sherman, MD;
Soo G. Kim, MD;
Bradley S. Boop, MD;
Scott D. Corley, MD;
John P. DiMarco, MD;
Robert G. Hart, MD;
L. Julian Haywood, MD;
Keith Hoyte, MD;
Elizabeth S. Kaufman, MD;
Michael H. Kim, MD;
Elaine Nasco, MD;
Albert L. Waldo, MD; for the National Heart, Lung, and Blood Institute AFFIRM Investigators
Arch Intern Med. 2005;165:1185-1191.
Background Atrial fibrillation (AF) is a risk factor for stroke, especially when accompanied by other high-risk cardiovascular predictors. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study was a multicenter comparison of high-risk patients with AF who were randomized to either a sinus rhythm control or a rate control strategy.
Methods Physicians were encouraged to continue anticoagulation therapy for their patients. Patients in the sinus rhythm control group could stop warfarin sodium therapy after 4 (preferably a minimum of 12) weeks if they maintained sinus rhythm while receiving an antiarrhythmic drug.
Results The AFFIRM Study enrolled 4060 patients. Mortality was the same in both groups. Two hundred eleven patients (8.2%) had a stroke event. Ischemic stroke occurred in 157 patients (6.3%), primary intraparenchymal hemorrhage in 34 (1.2%), and subdural or subarachnoid hemorrhage in 24 (0.8%). The most frequently determined ischemic stroke mechanism was cardioembolic (35/71 [49%]). Treatment assignment had no significant effect on the occurrence of ischemic stroke. Patients in AF at the time of the stroke event had a 60% greater chance of having an ischemic stroke, and those taking warfarin at the time of follow-up had a 69% decrease in the risk of having an ischemic stroke.
Conclusions In the AFFIRM Study, stroke rates were not significantly different in the rate control and sinus rhythm control arms. However, several clinical and therapeutic variables were associated with stroke risk. In patients with a history of AF at high risk for stroke or death, the presence of AF increases the risk of having a stroke, and warfarin therapy reduces the risk of having a stroke. The beneficial effect of warfarin therapy is seen not only in patients in AF but also in patients with a history of AF but who presumably remain in sinus rhythm.
Author Affiliations: University of Texas Health Science Center, San Antonio (Drs Sherman and Hart); Montefiore Medical Center, Bronx, NY (Dr S. G. Kim); Little Rock, Ark (Dr Boop); Axio Reseach Corp, Seattle, Wash (Drs Corley and Nasco); University of Virginia, Charlottesville, Va (Dr DiMarco); Keck School of Medicine, University of Southern California, Los Angeles, Calif (Dr Haywood); University of Calgary, Calgary, Alberta (Dr Hoyte); Case Western Reserve, Cleveland, Ohio (Drs Kaufman and Waldo); Rush-Presbyterian–St Luke’s Medical Center, Chicago, Ill (Dr M. H. Kim).
Group Information: A complete listing of the members of the AFFIRM Study was previously published (Am Heart J. 2002;143:991-1001).
RELATED ARTICLE
Systematic Overview of Warfarin and Its Drug and Food Interactions
Anne M. Holbrook, Jennifer A. Pereira, Renee Labiris, Heather McDonald, James D. Douketis, Mark Crowther, and Philip S. Wells
Arch Intern Med. 2005;165(10):1095-1106.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Singer et al.
Chest 2008;133:546S-592S.
ABSTRACT
| FULL TEXT
Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation
Stroke Risk in Atrial Fibrillation Working Group
Stroke 2008;39:1901-1910.
ABSTRACT
| FULL TEXT
Surgical Treatment of Atrial Fibrillation
Voeller et al.
Card Surg Adult 2008;3:1375-1394.
FULL TEXT
Atrial fibrillation in the 'real world': undecided issues
Nieuwlaat et al.
Eur Heart J Suppl 2007;9:I122-I128.
ABSTRACT
| FULL TEXT
Atrial fibrillation ablation: evolution of the curative approach
Arrantes et al.
Eur Heart J Suppl 2007;9:I129-I135.
ABSTRACT
| FULL TEXT
Independent predictors of stroke in patients with atrial fibrillation: A systematic review
The Stroke Risk in Atrial Fibrillation Working Gro
Neurology 2007;69:546-554.
ABSTRACT
| FULL TEXT
Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation
Shen et al.
J Am Coll Cardiol 2007;50:309-315.
ABSTRACT
| FULL TEXT
Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study
Rienstra et al.
Eur Heart J 2007;28:741-751.
ABSTRACT
| FULL TEXT
Stroke Prevention in Atrial Fibrillation: Pharmacological Rate Versus Rhythm Control
Sherman
Stroke 2007;38:615-617.
ABSTRACT
| FULL TEXT
Antithrombotic treatment in atrial fibrillation
Kalra et al.
Heart 2007;93:39-44.
FULL TEXT
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:651-745.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:854-906.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:e149-e246.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:e257-e354.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:700-752.
FULL TEXT
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Authors/Task Force Members et al.
Eur Heart J 2006;27:1979-2030.
FULL TEXT
Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Chan et al.
J Am Coll Cardiol 2006;47:2513-2520.
ABSTRACT
| FULL TEXT
Evidently...
Lehman
Evid. Based Med. 2006;11:6-6.
FULL TEXT
Other articles noted
Evid. Based Med. 2006;11:31-32.
FULL TEXT
The Euro Heart Survey on atrial fibrillation: a picture and a thousand words
Wyse
Eur Heart J 2005;26:2356-2357.
FULL TEXT
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas
Hart et al.
Stroke 2005;36:1588-1593.
ABSTRACT
| FULL TEXT
|
